Silexion Therapeutics SLXN
NASDAQ SLXN
$0.17 +0.01 (+7.74%)
As of: Oct 21, 2026 · 12:46 PM EDT

Silexion Therapeutics (SLXN) Acquisitions (2024)

Updated

Silexion Therapeutics (SLXN) posted Acquisitions of $2.3 million for FY2024.

Analysis

Silexion Therapeutics (SLXN) Acquisitions (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Eli Lilly 1,134.62 Bn 1,103.20 Bn 19.71 Bn 8.75 Bn
2 Johnson & Johnson 616.94 Bn 535.47 Bn 17.26 Bn -17.24 Bn
3 AbbVie 501.32 Bn 474.43 Bn 12.70 Bn -
4 Merck 367.44 Bn 321.82 Bn 12.21 Bn -
5 Novartis Ag 298.20 Bn 262.19 Bn 11.24 Bn 23.00 Mn
6 Astrazeneca 261.78 Bn 235.47 Bn 12.86 Bn -
7 Amgen 235.70 Bn 191.10 Bn 7.24 Bn -
8 Gilead Sciences 190.88 Bn 165.07 Bn 6.22 Bn 11.21 Bn
9 Pfizer 169.72 Bn 116.36 Bn 10.94 Bn -
10 Silexion Therapeutics 113,894.39 -19.76 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 -2.30 Mn
API Access

Silexion Therapeutics Acquisitions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=acquisitions&ticker=SLXN&period=max&api_key=YOUR_API_KEY